[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.47, "open": 4.63, "dayLow": 4.3977, "dayHigh": 4.8, "regularMarketPreviousClose": 4.47, "regularMarketOpen": 4.63, "regularMarketDayLow": 4.3977, "regularMarketDayHigh": 4.8, "payoutRatio": 0.0, "beta": 0.477, "volume": 94337, "regularMarketVolume": 94337, "averageVolume": 2123901, "averageVolume10days": 102860, "averageDailyVolume10Day": 102860, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 20845416, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 5.14, "fiftyDayAverage": 3.6512, "twoHundredDayAverage": 2.11615, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 19502080, "profitMargins": 0.0, "floatShares": 4267657, "sharesOutstanding": 4561360, "sharesShort": 44364, "sharesShortPriorMonth": 122174, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0097, "heldPercentInsiders": 0.108459994, "heldPercentInstitutions": 0.06336, "shortRatio": 0.21, "shortPercentOfFloat": 0.0098, "impliedSharesOutstanding": 4561360, "bookValue": 0.236, "priceToBook": 19.364407, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -3088952, "trailingEps": -1.28, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.3556702, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 4.57, "recommendationKey": "none", "totalCash": 887212, "totalCashPerShare": 0.195, "totalDebt": 0, "quickRatio": 1.652, "currentRatio": 1.843, "returnOnAssets": -0.99791, "returnOnEquity": -2.1320798, "freeCashflow": -1292541, "operatingCashflow": -2612238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.28, "fiftyDayAverageChange": 0.9188001, "fiftyDayAverageChangePercent": 0.25164333, "twoHundredDayAverageChange": 2.4538503, "twoHundredDayAverageChangePercent": 1.1595825, "corporateActions": [], "marketState": "CLOSED", "regularMarketChangePercent": 2.23714, "regularMarketPrice": 4.57, "postMarketTime": 1757116054, "regularMarketTime": 1757102401, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": 1.09409, "postMarketPrice": 4.62, "postMarketChange": 0.0499997, "regularMarketChange": 0.1, "regularMarketDayRange": "4.3977 - 4.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2123901, "fiftyTwoWeekLowChange": 3.9300003, "fiftyTwoWeekLowChangePercent": 6.1406255, "fiftyTwoWeekRange": "0.64 - 5.14", "fiftyTwoWeekHighChange": -0.5699997, "fiftyTwoWeekHighChangePercent": -0.11089489, "fiftyTwoWeekChangePercent": 135.56702, "dividendDate": 1605830400, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]